false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - Critica ...
Emerging Tools in ICU Nephrology: Biomarkers, Prev ...
Emerging Tools in ICU Nephrology: Biomarkers, Prevention Pathways, and Targeted Therapies
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Jay Koiner reviewed emerging tools and treatments for acute kidney injury (AKI) in the ICU. He discussed updated diagnostic criteria incorporating serum creatinine, cystatin C, urine output based on ideal body weight, and structural biomarkers. Because creatinine is imperfect during acute illness, cystatin C can better reflect GFR when muscle mass changes.<br /><br />He highlighted practical tests that are already widely available: the furosemide stress test can help predict AKI progression, while urine albumin and microscopy can identify injury and guide diagnosis. By contrast, fractional excretion of sodium is unreliable in most settings and should generally be reserved for cirrhosis-associated AKI.<br /><br />Evidence suggests AKI care bundles and alerts can improve care and sometimes outcomes, but alerts alone may prompt inappropriate treatment. Effective systems need clear action plans, and clinicians should address persistent gaps in medication review, fluid assessment, and prevention of nephrotoxic exposure.<br /><br />Among potential therapies, bicarbonate may reduce the need for dialysis in severe acidemia, and angiotensin II may benefit selected patients, particularly those with high renin. Evidence for SGLT2 inhibitors and amino-acid infusions remains more uncertain; changes in urine output or creatinine do not necessarily prove that kidney injury was prevented.<br /><br />Koiner urged clinicians to use available biomarkers and advocate for better AKI care, while remaining cautious about emerging treatments.
Asset Caption
Jay L. Koyner, MD, FASN
Meta Tag
Speaker
Jay L. Koyner
Keywords
acute kidney injury
AKI
ICU
cystatin C
furosemide stress test
AKI care bundles
nephrotoxic exposure
×
Please select your language
1
English